Cerebellar Stimulation and Cognitive Control
200
about 8 years
18–90
1 site in IA
About this study
This trial is testing if cerebellar stimulation can improve cognitive function and mood in people with schizophrenia, autism, bipolar disorder, Parkinson's disease, or depression. The treatment involves a device that delivers repetitive transcranial magnetic stimulation (rTMS).
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Repetitive Transcranial Magnetic Stimulation (rTMS)
- 2.Use Sham Repetitive Transcranial Magnetic Stimulation (rTMS)
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Primary: Change in disease-specific symptom rating scale, one scale identified for each group (MADRS for bipolar group; PANSS for schizophrenia group; UPDRS in Parkinson's patient group).
Secondary: Change in PHQ9 score., Change in cognitive function, Changes in MRI-based timing task., Changes in T1 rho MRI signal., Changes in functional MRI, Changes in structural MRI., Schizophrenia group: Change in Calgary depression scale.
therapeutic
Neurology, Psychiatry / Mental Health